Enhanced Nutraceutical Gel Systems and Methods

Publication ID: 24-11857593_0001_PTD
Published: October 28, 2025
Category:Direct Improvements & Enhancements

Legal Citation

pr1or.art Inc., “Enhanced Nutraceutical Gel Systems and Methods,” Published Technical Disclosure No. 24-11857593_0001_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857593_0001_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,593.

Summary of the Inventive Concept

The present inventive concept relates to novel systems and methods for creating customized nutraceutical gels with improved bioavailability, prolonged shelf life, and enhanced immune modulator delivery.

Background and Problem Solved

The original patent disclosed limitations in terms of fixed compositions and manufacturing processes, which restricted the ability to customize and optimize nutraceutical gels for specific user needs. The present inventive concept addresses these limitations by introducing modular systems and methods that enable the creation of tailored nutraceutical gels with improved performance.

Detailed Description of the Inventive Concept

The inventive concept encompasses four primary aspects: 1) a system for creating customized nutraceutical gels, comprising a gel matrix forming unit and a transfer factor dispensing unit; 2) a method for enhancing the bioavailability of an immune modulator in a nutraceutical gel, involving pH-level optimization; 3) a nutraceutical gel composition incorporating a bioavailability enhancer; and 4) a device for creating nutraceutical gels with customizable immune modulator concentrations. These aspects work in concert to provide a comprehensive solution for the production of optimized nutraceutical gels.

Novelty and Inventive Step

The present inventive concept introduces a paradigm shift in nutraceutical gel manufacturing by providing modular, customizable systems and methods that overcome the fixed composition limitations of the original patent. The use of pH-level optimization, bioavailability enhancers, and customizable immune modulator concentrations represents a significant departure from the prior art.

Alternative Embodiments and Variations

Alternative embodiments may include variations in the gel matrix forming unit, such as the use of different polymers or gelling agents. Additionally, the transfer factor dispensing unit could be modified to accommodate different types of immune modulators or bioavailability enhancers. Further, the device for creating nutraceutical gels could be adapted for use in different settings, such as clinical or commercial environments.

Potential Commercial Applications and Market

The present inventive concept has significant commercial potential in the nutraceutical and pharmaceutical industries, where customized and optimized gel-based products are in high demand. Target markets may include health and wellness companies, pharmaceutical manufacturers, and research institutions seeking to develop novel nutraceutical products.

CPC Classifications

SectionClassGroup
A A61 A61K36/889
A A23 A23G4/12
A A23 A23L29/231
A A23 A23L29/238
A A23 A23L29/27
A A23 A23L29/271
A A23 A23L29/284
A A23 A23L33/10
A A23 A23L33/105
A A61 A61K36/185
A A61 A61K36/35
A A61 A61K36/87
A A61 A61K47/36
A A23 A23V2002/00
A A23 A23V2200/324
A A23 A23V2250/21
A A23 A23V2250/21166
A A23 A23V2250/506
A A23 A23V2250/5086
A A23 A23V2250/708
A A61 A61K2300/00

Original Patent Information

Patent NumberUS 11,857,593
TitleNutraceutical gels
Assignee(s)4Life Patents, LLC